(NYSE:IQV) today announced that Jon Resnick, IQVIA’s president,
Real-World & Analytics Solutions, has been named to PharmaVOICE
magazine’s annual list of the 100 most influential and inspiring
individuals within the life sciences industry.
“IQVIA has created platforms driving collaborations across payers,
providers, and life sciences that will ultimately help patients. I am
very proud that Jon who has been at the forefront of these efforts has
been recognized for his leadership in advancing the industry’s adoption
of real-world evidence,” said IQVIA Chairman and CEO Ari Bousbib.
Resnick, who was nominated by John Hervey, CEO of healthcare data and
analytics company Cota Inc., has led the transformation of the way
real-world evidence is generated and applied using advances such as
machine learning, federated platforms, novel methodologies, and SaaS
technologies. By bringing new data sources, deeper scientific expertise,
and purpose-built technologies to solve complex challenges, IQVIA teams
are offering breakthrough solutions across product lifecycles from R&D
effectiveness to innovative contracting to more precise
commercialization models. They also work directly with public health
organizations, providers and other stakeholders to champion a
cross-stakeholder collaborative approach to understand, measure and
optimize value and patient outcomes spanning the healthcare system.
“As I have come to know Jon, it has become clear that I am not the only
one who has benefited from his strategic thinking,” said Hervey. “For
more than a decade, healthcare technology and analytics have been a
passion for him. Jon has proven himself to be an adaptive leader who
excels at bringing diverse teams together to pursue a common goal. The
breadth of his experience and innovative thinking will enable us to
leverage the insights derived from real-world evidence to make a
positive impact on the future of healthcare.”
The annual PharmaVOICE 100 list celebrates inspirational, motivational,
and transformative individuals in life sciences who positively impact
their colleagues, peers, organizations, and the industry. These
individuals think bigger, do more, and lead with passion and integrity.
To read the PharmaVOICE profiles, visit www.pharmavoice.com.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics,
technology solutions and contract research services to the life sciences
industry. Formed through the merger of IMS Health and Quintiles, IQVIA
applies human data science — leveraging the analytic rigor and clarity
of data science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 55,000
employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
the information that helps their customers drive human health outcomes
forward. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap into a
deeper understanding of diseases, human behaviors and scientific
advances, in an effort to advance their path toward cures. To learn
more, visit www.iqvia.com.
here to subscribe to Mobile Alerts for IQVIA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180801005476/en/